PKTXOTCPharmaceutical PreparationsFiscal year ends December 31
ProtoKinetix, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-K on Sep 3, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $78.61K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0050 (−96.15%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- $78.61K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.26
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$393.65K
- EPS, diluted
- $0.00
- Book value per share
- $0.00
- Diluted shares
- 393M
Fifteen years at a glance
Fiscal years 2011 to 2025, USD
Revenue
–
Operating income
–
Net income
-$393.65K
EPS, diluted
$0.00
Reported period